miRNAs in anti-cancer drug resistance of non-small cell lung cancer: Recent advances and future potential

Non-small cell lung cancer (NSCLC) is one of the most common malignant tumors worldwide. Clinical success is suboptimal owing to late diagnosis, limited treatment options, high recurrence rates, and the development of drug resistance. MicroRNAs (miRNAs), a range of small endogenous non-coding RNAs t...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Hang, Tang, Shengjie, Tang, Shoujun, Zhang, Jun, Guo, Haiyang, Qin, Chao, Hu, Haiyang, Zhong, Chuan, Yang, Li, Zhu, Yunhe, Zhou, Haining
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9640411/
https://www.ncbi.nlm.nih.gov/pubmed/36386184
http://dx.doi.org/10.3389/fphar.2022.949566

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9640411/
https://www.ncbi.nlm.nih.gov/pubmed/36386184
http://dx.doi.org/10.3389/fphar.2022.949566

Ejemplares similares